Literature DB >> 10472523

Harmonic imaging: echocardiographic enhanced contrast intensity and duration.

M R Allen1, P A Pellikka, H R Villarraga, K W Klarich, D A Foley, S L Mulvagh, J B Seward.   

Abstract

The intensity and duration of contrast effect within the left ventricular cavity after an intravenous bolus of Levovist Injection were observed with both harmonic and fundamental imaging in nine patients with known or suspected coronary artery disease. Contrast intensity was assessed by a qualitative grading system (0, none; 1, weak; 2, moderate; 3, good) and by videodensitometric analysis of pixel intensity. Duration of left ventricular contrast effect was determined by measuring time from the initial visual appearance of contrast agent to its disappearance. The mean increase in pixel intensity within the left ventricular cavity from precontrast to peak contrast was significantly greater for second harmonic than for fundamental imaging (25.5 vs 7.1; P < 0.012). The mean contrast intensity qualitative score with harmonic imaging was higher (2.6 +/- 0.73 vs 1.2 +/- 0.44; P < 0.01) and the duration of contrast effect was longer (242 +/- 131 s vs 53 +/- 33 s; P < 0.004). Second harmonic imaging significantly enhanced contrast intensity and prolonged visible duration of contrast effect after a peripheral venous injection of Levovist.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472523     DOI: 10.1023/a:1006140102056

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  10 in total

1.  Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent.

Authors:  R Schlief; T Staks; M Mahler; M Rufer; T Fritzsch; W Seifert
Journal:  Echocardiography       Date:  1990-01       Impact factor: 1.724

Review 2.  Principles and recent developments in ultrasound contrast agents.

Authors:  N de Jong; F J Ten Cate; C T Lancée; J R Roelandt; N Bom
Journal:  Ultrasonics       Date:  1991-07       Impact factor: 2.890

Review 3.  Contrast echocardiography 1996. A review.

Authors:  H R Villarraga; D A Foley; S L Mulvagh
Journal:  Tex Heart Inst J       Date:  1996

4.  Second harmonic imaging of an intravenously administered echocardiographic contrast agent: Visualization of coronary arteries and measurement of coronary blood flow.

Authors:  S L Mulvagh; D A Foley; B C Aeschbacher; K K Klarich; J B Seward
Journal:  J Am Coll Cardiol       Date:  1996-05       Impact factor: 24.094

5.  Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin.

Authors:  T R Porter; F Xie; D Kricsfeld; R W Armbruster
Journal:  J Am Coll Cardiol       Date:  1996-05       Impact factor: 24.094

6.  Second harmonic ultrasonic blood perfusion measurement.

Authors:  B A Schrope; V L Newhouse
Journal:  Ultrasound Med Biol       Date:  1993       Impact factor: 2.998

7.  [Stress echocardiography: evaluation of left ventricular function after administration of the transpulmonary echo contrast medium SHU 508 A].

Authors:  S Beckmann; M Schartl; W Bocksch; H Paeprer
Journal:  Z Kardiol       Date:  1993-05

8.  Improvement of endocardial border delineation in suboptimal stress-echocardiograms using the new left heart contrast agent SH U 508 A.

Authors:  K Schröder; R Agrawal; H Völler; R Schlief; R Schröder
Journal:  Int J Card Imaging       Date:  1994-03

9.  Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging.

Authors:  T R Porter; S Li; D Kricsfeld; R W Armbruster
Journal:  J Am Coll Cardiol       Date:  1997-03-15       Impact factor: 24.094

10.  Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group.

Authors:  H von Bibra; G Sutherland; H Becher; J Neudert; P Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

  10 in total
  7 in total

1.  Contrast echocardiography for left ventricular opacification.

Authors:  J Timperley; A R J Mitchell; H Becher
Journal:  Heart       Date:  2003-12       Impact factor: 5.994

2.  Impact of Contrast Echocardiography on Assessment of Ventricular Function and Clinical Diagnosis in Routine Clinical Echocardiography: Korean Multicenter Study.

Authors:  Doo-Youp Kim; Jung-Hyun Choi; Geu-Ru Hong; Se-Joong Rim; Jang-Young Kim; Sang-Chol Lee; Il-Suk Sohn; Wook-Jin Chung; Hye-Sun Seo; Se-Jung Yoon; Kyoung-Im Cho; Si-Wan Choi; Kyung-Jin Lee
Journal:  J Cardiovasc Ultrasound       Date:  2017-03-27

Review 3.  [Assessment of systolic function in patients with poor echogenicity: echocardiographic methods].

Authors:  F Weidemann; D Liu; M Niemann; S Herrmann; H Hu; P D Gaudron; G Ertl; K Hu
Journal:  Herz       Date:  2013-08-15       Impact factor: 1.443

4.  Clinical application and laboratory protocols for performing contrast echocardiography.

Authors:  Adrian Chong; Brian Haluska; Sudhir Wahi
Journal:  Indian Heart J       Date:  2013-04-06

Review 5.  Morbid obesity: obscuring the diagnosis of aortic stenosis in a patient with cardiogenic wheezing.

Authors:  Eric D Morrell; William E Katz; Asher A Tulsky
Journal:  J Gen Intern Med       Date:  2012-07-19       Impact factor: 5.128

Review 6.  Advanced echocardiographic techniques.

Authors:  Rebecca Perry; Majo Joseph
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

7.  Pretest score for predicting microbubble contrast agent use in stress echocardiography: a method to increase efficiency in the echo laboratory.

Authors:  Mathieu Bernier; Sahar S Abdelmoneim; Stuart Moir; Robert B McCully; Patricia A Pellikka; Sharon L Mulvagh
Journal:  Cardiol Res Pract       Date:  2009-07-21       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.